对照组静点低分子右旋糖苷，口服安慰剂胶囊(淀粉)。
Patients in the control group were treated with low molecular dextran and placebo (made with starch).
低分子肝素抗凝、低分子右旋糖苷扩容为其主要的治疗手段。
The main treatment was low molecular weight heparin anticoagulation and low molecular weight dextran expansion.
结论：低分子右旋糖苷不良反应涉及多个系统，应合理应用低分子右旋糖苷，尽量减少不良反应的发生。
Conclusion: the side reaction of low molecule dextran involves several system, so to reduce the side reaction by administration reasonably.
应用推荐